Articles From: Ultragenyx Announces Positive Interim Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7 to Hallador Energy Announces Investor Call to Discuss Sunrise Coal's Acquisition of Vectren Fuels


ATHENS, Greece, Sept.
Sign-up for TOP Ships Inc. Announces Increase of Independent Directors investment picks
- Accelerates Adoption through Complementary Sales Channels - Enhances 3DS' Metal Printing and Manufacturing Service Capabilities - Expands 3DS' IP, Technology Platform and Medical Device Productions - Extends 3DS' Direct Metal Printer Expertise and Product Portfolio - Expected to be Immediately Accretive to Cash Generation ROCK HILL, S.C., Sept.
Sign-up for Photo Release -- 3D Systems Acquires LayerWise, Extending Its Global Leadership in Advanced Metal 3D Printing, On-Demand Parts Manufacturing Services and Personalized Medical Devices investment picks
SAN DIEGO, Sept.
Sign-up for Biocept Strengthens Its Circulating Tumor Cell IP Position in Europe investment picks
HILLSBORO, Ore., Sept.
Sign-up for FEI Releases New Helios NanoLab G3 DualBeam investment picks
HILLSBORO, Ore., Sept.
Sign-up for FEI Announces Teneo VS for 3D Volume Imaging of Cells and Tissues investment picks
DURHAM, N.C., Sept.
Sign-up for Chimerix's Brincidofovir Has in Vitro Activity Against Ebola investment picks
DANVERS, Mass., Sept.
Sign-up for Abiomed to Present at the Morgan Stanley Global Healthcare Conference 2014 investment picks
LAVAL, Quebec, Sept.
Sign-up for Neptune to Present at Rodman & Renshaw Global Investment Conference investment picks
PORTLAND, Ore., Sept.
Sign-up for Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference investment picks
The randomized, double-blind, placebo-controlled, parallel group Phase III study with RHB-102 (the GUARD study) will enroll 320 acute gastroenteritis patients in the U.S. Acute gastroenteritis is an inflammation of the gastrointestinal tract causing nausea and vomiting, with a potential worldwide market estimated to exceed $650 million If approved for marketing by the FDA, RHB-102 is expected to be the first-ever 5-HT3 antagonist drug indicated for acute gastroenteritis Dr.
Sign-up for RedHill Biopharma Initiates Phase III Study of RHB-102 for Gastroenteritis investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst to Present at Rodman & Renshaw Conference investment picks
FORT WORTH, Texas, Sept.
Sign-up for ALLIED ELECTRONICS EARNS AS9120A CERTIFICATION investment picks
WINTER SPRINGS, Fla., Sept.
Sign-up for IRADIMED CORPORATION Announces Receipt of FDA Warning Letter investment picks
TORRANCE, Calif., Sept.
Sign-up for Farmer Bros. Co. to Report Fourth Quarter and Year End Fiscal 2014 Results on September 9, 2014 investment picks
MARTINSVILLE, Va., Sept.
Sign-up for Hooker Furniture to Host Second Quarter Earnings Call September 10 investment picks
VALENCIA, Calif., Sept.
Sign-up for MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference investment picks
MANCHESTER, Conn., Sept.
Sign-up for Lydall to Attend Global Hunter Securities 3rd Annual Industrials Day investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Ultragenyx Announces Positive Interim Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7 to Hallador Energy Announces Investor Call to Discuss Sunrise Coal's Acquisition of Vectren Fuels
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent